Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Ann: Scheme Update, page-91

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 91 Last

Share
Profile

Follow
.@#.

666 Posts.

75

04/07/22

07:48

Post #: 62348365
Share

Originally posted by Cosmoclarke: ↑

I guess this isn’t a very popular opinion here, but…. As I’ve said before , the company has struggled to market dx, maybe because of the medical fraternity being difficult to convince, and/or FDA being loathe to ratify the product either because of lack of evidence or lack of support from big pharma.
So we need to keep going with covid testing, as this will bring in revenue, which can then be used to push dx to the world.

It is not going to be easy to convince medical professionals, and we need advertising, advertising and more advertising. We need more exposure, more data, and more staff. We need board members and staff that are qualified to do this, therefore we need to pay more to keep them .
Why does Pfizer want Covid testing? Simple, because it will bring in revenue, fast. So the company needs to move with this opportunity , so that acceptance of dx will follow on the coattails of the acceptance of covid testing, and we can keep on funding the RAP core product…DX.

Flogging the same poor ole horse , the same way , will mean the company will run out of money, and probably add years to the world wide acceptance of DX.

My opinion only.

Expand

Have you come across the Clinical Trials Transformation Initiative, by chance? Apparently Pfizer are a member...

RAP Price at posting: 13.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 42 more messages in this thread...

First 91 Last

Add RAP (ASX) to my watchlist

Ann: Scheme Update, page-91

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News